USD 0.01
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -593.7 Thousand | -1.99 Million | -1.37 Million | - | -1.87 Million | -1.87 Million |
Net Income | -674.4 Thousand | - | - | - | - | - |
Depreciation & Amortization | 1201.39 | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -34.49 Thousand | - | - | - | - | - |
Other non-cash items | 113.98 Thousand | - | - | - | - | - |
Investing Cash Flow | -1521.00 | -8068.00 | -2013.00 | - | -5270.00 | -37.36 Thousand |
Investments in PPE | -1521.00 | -8068.00 | -2013.00 | - | -5270.00 | -2086.00 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | -35.27 Thousand |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 479.73 Thousand | 316.61 Thousand | 1.83 Million | 2.32 Million | 1.98 Million | 1.65 Million |
Debt repayment | -57.62 Thousand | -331.5 Thousand | - | - | -205.89 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -3548.00 | -870.00 | -145.46 Thousand | -188.59 Thousand | -97.94 Thousand | -87.82 Thousand |
Common Stock Issuance | 551.99 Thousand | - | 1.98 Million | 2.53 Million | 2.15 Million | 1.74 Million |
Other Financing Activities | -11.07 Thousand | 317.48 Thousand | - | -17.3 Thousand | -73.08 Thousand | - |
Accounts receivables | -38.82 Thousand | - | - | - | - | - |
Accounts payables | 4329.47 | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 135.46 Thousand | 1.76 Million | 1.37 Million | 154.58 Thousand | 49.78 Thousand | 323.33 Thousand |
Cash at end of period | 26.71 Thousand | 135.46 Thousand | 1.76 Million | 1.37 Million | 154.58 Thousand | 27.34 Thousand |
Capital Expenditure | -1521.00 | -8068.00 | -2013.00 | - | -5270.00 | -2086.00 |
Effect of forex changes on cash | -105.00 | 63.58 Thousand | -77.16 Thousand | -8846.00 | 4575.00 | -39.18 Thousand |
Net cash flow / Change in cash | -108.74 Thousand | -1.62 Million | 384.35 Thousand | 1.22 Million | 104.8 Thousand | -295.98 Thousand |
Free Cash Flow | -595.22 Thousand | -2 Million | -1.37 Million | - | -1.88 Million | -1.87 Million |
Breakdown | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -215.18 Thousand | -428.95 Thousand | -205.55 Thousand | - | -971.25 Thousand | -492.59 Thousand |
Depreciation & Amortization | - | 16.45 Thousand | 7886.00 | - | 10.82 Thousand | 246.00 |
Deferred income taxes | - | - | - | - | -38.27 Thousand | 0.60 |
Stock-based compensation | - | - | - | - | 22.96 Thousand | 22.96 Thousand |
Change in working capital | - | - | - | - | -11.88 Thousand | -11.88 Thousand |
Other non-cash items | 17.85 Thousand | 39.9 Thousand | 3349.00 | - | 130.66 Thousand | 44.63 Thousand |
Investing Cash Flow | -1540.52 | 312.16 | - | -8068.00 | -7953.91 | -4034.00 |
Investments in PPE | 194.05 Thousand | - | - | -8068.00 | -7953.91 | -4034.00 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1540.52 | - | - | - | - | - |
Financing Cash Flow | 125.56 Thousand | 367.99 Thousand | 176.34 Thousand | 316.61 Thousand | 312.14 Thousand | 158.3 Thousand |
Debt repayment | -58.36 Thousand | -192.69 Thousand | - | -331.5 Thousand | -326.81 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | -870.00 | - | - |
Common Stock Issuance | -4837.29 | 572.24 Thousand | - | - | -857.70 | - |
Other Financing Activities | 133.09 | 176.34 Thousand | 176.34 Thousand | 317.48 Thousand | 158.3 Thousand | 158.3 Thousand |
Accounts receivables | - | - | - | - | -4883.00 | -4883.00 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | -7006.00 | -7006.00 |
Cash at beginning of period | 95.7 Thousand | 135.53 Thousand | -10.98 Thousand | 1.76 Million | 593.8 Thousand | 590.97 Thousand |
Cash at end of period | 26.66 Thousand | 95.7 Thousand | -30.75 Thousand | 135.46 Thousand | 135.53 Thousand | 527.4 Thousand |
Capital Expenditure | 194.05 Thousand | - | - | -8068.00 | -7953.91 | -4034.00 |
Effect of forex changes on cash | - | -1794.00 | -1794.00 | 63.58 Thousand | 54.59 Thousand | 54.59 Thousand |
Net cash flow / Change in cash | -69.03 Thousand | -39.82 Thousand | -19.76 Thousand | -1.62 Million | -458.27 Thousand | -63.57 Thousand |
Free Cash Flow | -3271.00 | -405.5 Thousand | -194.32 Thousand | -2 Million | -859.36 Thousand | -440.66 Thousand |
LGO
600798
TRIGYN
CLI
UNIENTER
ESPA3